| Literature DB >> 35371821 |
Ahmad M Odeh1, Kawthar A Boumarah2, Wejdan A Alsumaien3, Mohmmed T Al-Abbad4, Aminah H Al-Ali4, Zainab A Alammar5, Hesham Alsuqair5, Abdulqader M Albeladi1, Abdulmohsen Alsuwaigh6, Ammar Omrani7, Mohammed M Almuhanna4, Zaki Busbaih4, Hussain R Al-Shaban5, Abrar A Aldhameen5.
Abstract
Nontraumatic splenic rupture and hematoma are rare in sickle cell disease. We present a case of a 22-year-old Saudi male with sickle cell disease. He presented to our hospital with a history of nontraumatic abdominal pain, hemodynamic instability, and abdominal tenderness, with a large mass extending to the umbilicus. A computed tomography (CT) examination showed splenomegaly and a spleen infarction. The patient was admitted to the intensive care unit (ICU) and stabilized. He was transferred to the regular ward and discharged against medical advice (DAMA). Later on, he presented again with persistent abdominal pain. He underwent splenectomy with cholecystectomy. The patient did well postoperatively and was discharged in good condition. While conservative management is common, operative management should be considered in patient with persistent pain. Splenic rupture has a high mortality rate.Entities:
Keywords: cholecystectomy; sickle cell disease; sickle cell disease complications; splenectomy; splenic hematoma
Year: 2022 PMID: 35371821 PMCID: PMC8958125 DOI: 10.7759/cureus.22582
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Abdominal ultrasound showing multiple gall bladder stones (A) and splenic enlargement measuring 15.9 cm (B).
Figure 2Abdomen CT scan showing spleen enlargement and a large subcapsular fluid collection.
Laboratory investigations in the first ICU admission, third day in ICU admission, and the discharge day.
WBC: white blood cell; Hb: hemoglobin; PLT: platelet; ALP: alkaline phosphatase; AST: aspartate aminotransferase; ALT: alanine transaminase; bili: bilirubin; K: potassium; Na: sodium; INR: international normalized ratio; PT: prothrombin time; PTT: partial prothrombin time; FBS: fasting blood glucose
| Lab parameters | First ICU admission (March 21, 2021) | Third day in ICU (March 23, 2021) | On first discharge (April 4, 2021) | Normal values |
| WBC | 17.8 | 30.66 | 16 | 4-10 × 109/L |
| Hb | 11.8 | 7.7 | 7.4 | 12-15 g/dL |
| PLT | 268 | 47 | 830 | 130-400 × 109 |
| Albumin | 36.6 | 39.6 | 30 | 30-50 g/dL |
| ALP | 560 | 490 | 89 | 50-136 IU/L |
| AST | 528 | 877.8 | 25.8 | 0-40 IU/L |
| ALT | 70 | 601.90 | 51.3 | 30-65 IU/L |
| Total bili | 72.2 | 57.1 | 24.5 | 0-24 mmol/L |
| Direct bili | 7.05 | 11.3 | 9.9 | 0-5 mmol/L |
| FBS | 7.4 | 7.73 | 4.41 | 4.1-8.3 mmol/L |
| K | 3.11 | 6.52 | 4.41 | 3.4-5.1 mmol/L |
| Na | 137 | 129 | 132 | 133-148 mmol/L |
| INR | 1.95 | 1.57 | - | 0.9-1.2% |
| PT | 22.9 | 18.4 | - | 9.8-13.2 s |
| PTT | 49.8 | 58.2 | - | 26- 36 s |
Figure 3The image is showing surgically excised specimens - (A) spleen, (B) splenic cyst, (C) gall bladder, and (D) gall stones.
Laboratory investigations in the elective admission for splenectomy and cholecystectomy.
WBC: white blood cell; Hb: hemoglobin; PLT: platelet; ALP: alkaline phosphatase; AST: aspartate aminotransferase; ALT: alanine transaminase; bili: bilirubin; K: potassium; Na: sodium; INR: international normalized ratio; PT: prothrombin time; PTT: partial prothrombin time
| Lab parameters | On first day of elective admission | On discharge | Normal values |
| WBC | 10.9 | 10.92 | 4-10 × 109/L |
| Hb | 11.3 | 13 | 12-15 g/dL |
| PLT | 320 | 597 | 130-400 × 109 |
| ALP | 99 | 104 | 50-136 IU/L |
| AST | 24.5 | 38.4 | 0-40 IU/L |
| ALT | 22.3 | 50.8 | 30-65 IU/L |
| Total bili | 82.6 | 51.7 | 0-24 mmol/L |
| Direct bili | 10.6 | 14.3 | 0-5 mmol/L |
| Fasting glucose | 5 | 3.95 | 4.1-8.3 mmol/L |
| K | 4.52 | 4.79 | 3.4-5.1 mmol/L |
| Na | 142 | 138 | 133-148 mmol/L |
| INR | 1.4 | 0.9-1.2% | |
| PT | 13.3 | 9.8-13.2 s | |
| PTT | 42.5 | 26-36 s |